Home

Terapio is a biopharmaceutical company developing therapeutics based on the membrane-associated RLIP76 protein. Initial applications include developing the RLIP76 protein as a medical countermeasure for radiation exposure and chemical threats to civilian, military and first responder populations. The RLIP76 protein primarily works though the oxidative stress pathway and provides protection as both a prophylactic and post exposure treatment by effluxing toxins.